Stomach cancer treatment with targeted therapy

When oncologists use targeted therapy, they aim to impact a substance (e. g. , proteins, hormones, enzymes, etc. ), gene, or a specific type of tumor cell receptors to acquire control over stomach cancer growth and development. Many different groups of medications and their combinations might be used during targeted therapy, including vascular endothelial growth factor blockers, mTOR pathway blockers, and many others. Often, various subtypes of stomach cancer might show complete resistance or better susceptibility to different types of targeted therapy. So, medical practitioners often prescribe genetic mutation tests to evaluate possible response rates that particular patients show during targeted therapy. Primarily, targeted therapy is delivered via intravenous injections, but oral forms for some medications are also available. On average, the procedure might take up to a few hours and require a patient to remain in the hospital for some time after the end. On average, patients with advanced stages of stomach therapy might need 6-10 courses of targeted therapy to achieve significant results.